595 related articles for article (PubMed ID: 32749010)
1. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
Shi W; Lv J; Lin L
J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
4. Thromboembolic events and Covid-19.
Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
[TBL] [Abstract][Full Text] [Related]
5. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
6. Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.
Wang J; Zhang H; Qiao R; Ge Q; Zhang S; Zhao Z; Tian C; Ma Q; Shen N
J Int Med Res; 2020 Sep; 48(9):300060520955037. PubMed ID: 32960106
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
Tal S; Spectre G; Kornowski R; Perl L
Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and SIC (!).
Nevzorov I; Tulamo R; Albäck A; Lassila R
J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
[No Abstract] [Full Text] [Related]
9. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
Betoule A; Martinet C; Gasperini G; Muller P; Foucher S; Benner P; Renard A
J Thromb Thrombolysis; 2020 Aug; 50(2):302-304. PubMed ID: 32504449
[No Abstract] [Full Text] [Related]
11. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
[No Abstract] [Full Text] [Related]
12. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
Görlinger K; Dirkmann D; Gandhi A; Simioni P
Anesth Analg; 2020 Nov; 131(5):1324-1333. PubMed ID: 33079850
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
Magro G
Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
[No Abstract] [Full Text] [Related]
15. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
[TBL] [Abstract][Full Text] [Related]
16. Peptides: Prospects for Use in the Treatment of COVID-19.
Khavinson V; Linkova N; Dyatlova A; Kuznik B; Umnov R
Molecules; 2020 Sep; 25(19):. PubMed ID: 32987757
[TBL] [Abstract][Full Text] [Related]
17. Foreword for the special issue advances in COVID-19: Biology and clinic.
McCubrey JA; Akula SM; Payrastre B
Adv Biol Regul; 2020 Aug; 77():100744. PubMed ID: 32773104
[No Abstract] [Full Text] [Related]
18. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.
Chen L; Long X; Xu Q; Tan J; Wang G; Cao Y; Wei J; Luo H; Zhu H; Huang L; Meng F; Huang L; Wang N; Zhou X; Zhao L; Chen X; Mao Z; Chen C; Li Z; Sun Z; Zhao J; Wang D; Huang G; Wang W; Zhou J
Cell Mol Immunol; 2020 Sep; 17(9):992-994. PubMed ID: 32620787
[No Abstract] [Full Text] [Related]
19. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
Emerg Infect Dis; 2020 Aug; 26(8):1941-1943. PubMed ID: 32348233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
